210 related articles for article (PubMed ID: 30179912)
21. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
Basu D; Siegel BA; McDonald DJ; Nussenbaum B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
[TBL] [Abstract][Full Text] [Related]
22. FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes.
Mapelli P; Broggi S; Incerti E; Alongi P; Kirienko M; Fiorino C; Dell Oca I; Fallanca F; Vanoli EG; Di Muzio NG; Gianolli L; Picchio M
Curr Radiopharm; 2017 Aug; 10(2):102-110. PubMed ID: 28412923
[TBL] [Abstract][Full Text] [Related]
23. Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx.
Kim MR; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Eur J Surg Oncol; 2007 Jun; 33(5):633-8. PubMed ID: 17391904
[TBL] [Abstract][Full Text] [Related]
24. F-18 FDG PET/CT imaging of anal canal squamous cell carcinoma.
Nguyen BD; Ram PC; Roarke MC
Clin Nucl Med; 2007 Mar; 32(3):234-6. PubMed ID: 17314608
[No Abstract] [Full Text] [Related]
25. PET/CT imaging of skeletal muscle metastases.
Surov A; Pawelka MK; Wienke A; Schramm D
Acta Radiol; 2014 Feb; 55(1):101-6. PubMed ID: 23884841
[TBL] [Abstract][Full Text] [Related]
26. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
[TBL] [Abstract][Full Text] [Related]
27. Diffuse skeletal muscle F-18 fluorodeoxyglucose uptake in advanced primary muscle non-Hodgkin's lymphoma.
Broski SM; Bou-Assaly W; Gross MD; Fig LM
Clin Nucl Med; 2009 Apr; 34(4):251-3. PubMed ID: 19300063
[TBL] [Abstract][Full Text] [Related]
28. Metastasis to skeletal muscle from esophageal adenocarcinoma.
Heyer CM; Rduch GJ; Zgoura P; Stachetzki U; Voigt E; Nicolas V
Scand J Gastroenterol; 2005 Aug; 40(8):1000-4. PubMed ID: 16165713
[TBL] [Abstract][Full Text] [Related]
29. The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinoma.
Taghipour M; Marcus C; Califano J; Fakhry C; Subramaniam RM
J Med Imaging Radiat Oncol; 2015 Dec; 59(6):681-6. PubMed ID: 26768092
[TBL] [Abstract][Full Text] [Related]
30. The value of 18-FDG PET/CT imaging in a patient with atypical metastatic colorectal cancer--case report: 18-FDG PET/CT in colorectal cancer.
Hlavatá Z; Pazderová N; Povinec P; Paulíny P; Majidi A; Fiala P; Martanovic P; Sálek T
Klin Onkol; 2009; 22(6):284-7. PubMed ID: 20099747
[TBL] [Abstract][Full Text] [Related]
31. Multiple metastases to skeletal muscle from carcinoma of the esophagus detected by FDG PET-CT imaging.
Heffernan E; Fennelly D; Collins CD
Clin Nucl Med; 2006 Dec; 31(12):810-1. PubMed ID: 17117081
[TBL] [Abstract][Full Text] [Related]
32. An unusual metastatic site of tongue carcinoma: shoulder muscles.
Yurut-Caloglu V; Caloglu M; Oz-Puyan F; Unlu E; Karagol H; Ibis K; Uzal C
Auris Nasus Larynx; 2008 Sep; 35(3):443-6. PubMed ID: 17964101
[TBL] [Abstract][Full Text] [Related]
33. Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
Ng SH; Lin CY; Chan SC; Lin YC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Chang CJ; Wang JJ
PLoS One; 2014; 9(12):e115933. PubMed ID: 25531391
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
[TBL] [Abstract][Full Text] [Related]
35. PET detection of solitary distant skeletal muscle metastasis of esophageal adenocarcinoma.
Wu G; Bybel B; Brunken R; Lin H; Neumann D
Clin Nucl Med; 2005 May; 30(5):335-7. PubMed ID: 15827406
[TBL] [Abstract][Full Text] [Related]
36. FDG PET/CT in 2 Cases of Renal Metastasis From Esophageal Squamous Cell Carcinoma.
Zhao Q; Dong A; Yang B; Wang Y; Zuo C
Clin Nucl Med; 2017 Nov; 42(11):896-898. PubMed ID: 28872547
[TBL] [Abstract][Full Text] [Related]
37. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
[TBL] [Abstract][Full Text] [Related]
38. Value of PET/CT 3D visualization of head and neck squamous cell carcinoma extended to mandible.
Lopez R; Gantet P; Julian A; Hitzel A; Herbault-Barres B; Alshehri S; Payoux P
J Craniomaxillofac Surg; 2018 May; 46(5):743-748. PubMed ID: 29567343
[TBL] [Abstract][Full Text] [Related]
39. Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple Myeloma.
Caldarella C; Annunziata S; Pagano L; De Stefano V; Rufini V
Clin Nucl Med; 2017 Feb; 42(2):e130-e134. PubMed ID: 27922862
[TBL] [Abstract][Full Text] [Related]
40. [Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in early detection of residual tumor in oro-pharyngeal-laryngeal carcinoma].
Haenggeli CA; Dulguerov P; Slosman D; Becker M; Bang P; Allal A; Guyot JP; Lehmann W
Schweiz Med Wochenschr Suppl; 2000; 116():8S-11S. PubMed ID: 10780061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
